Teriparatide
Teriparatide is a medication used to treat osteoporosis, a condition that weakens bones and makes them more prone to fractures. The medication works by stimulating bone formation and increasing bone mineral density, helping to reduce the risk of fracture.
In China, Teriparatide is marketed under the brand name Forteo and is available as an injection. It is approved for use in postmenopausal women with osteoporosis who are at high risk of fracture, as well as in men with primary or hypogonadal osteoporosis who are at high risk of fracture.
One of the main benefits of Teriparatide
One of the main benefits of Teriparatide is its ability to reduce the risk of vertebral and nonvertebral fractures. In clinical trials, patients taking Teriparatide experienced a significant reduction in the risk of fractures compared to those taking a placebo. Additionally, Teriparatide has been shown to improve bone mineral density and reduce bone turnover.
However, like all medications, Teriparatide can cause side effects.
Other Polypeptide APIs Products
peptide synthesis companies
| Polypeptide APIs Products |
| US-DMF LIST |
| Beauty peptides |
| Chinese cGMP APIs |
| Mexico Registered APIs |
| Research Peptide APIs for Regulatory Market |
| Polypeptide Preparation |
| Kaijie bio medicine Peptide APIs |